Live Breaking News & Updates on Douglask Bratton

Stay updated with breaking news from Douglask bratton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors


Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
February 09, 2021 07:30 ET
| Source:
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Warren, New Jersey, UNITED STATES
WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced the appointment of Julie Krop, M.D., Chief Medical Officer of Freeline Therapeutics (NASDAQ: FRLN), and Marco Taglietti, M.D., Director, President and Chief Executive Officer of SCYNEXIS (NASDAQ: SCYX), to the Board of Directors of the Company effective February 10, 2021. Aquestive also announced the resignation of Douglas K. Br ....

New York , United States , New Jersey , Fort Worth , Marco Taglietti , Stephanie Carrington , Douglask Bratton , Transcelerate Biopharma , Keith Kendall , Julie Krop , Regulatory Affairs For Stryker Biotech , Head Of Global Research , Research Development , Board Audit Committee , Development For Stiefel Laboratories Inc , Brown University School Of Medicine , Clinical Development For Vertex Pharmaceuticals , Forest Research Institute , Brown University , Clinical Development , Department Of Endocrinology , European Product Team Leader , Stiefel International Ltd , American Foundation For Suicide Prevention , Clinical Research Anti , Securities Exchange Commission ,